These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28404202)

  • 41. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?
    Perlman DC; Des Jarlais DC; Feelemyer J
    J Addict Dis; 2015; 34(2-3):198-205. PubMed ID: 26075647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recommendations for the management of hepatitis C virus infection among people who inject drugs.
    Robaeys G; Grebely J; Mauss S; Bruggmann P; Moussalli J; De Gottardi A; Swan T; Arain A; Kautz A; Stöver H; Wedemeyer H; Schaefer M; Taylor L; Backmund M; Dalgard O; Prins M; Dore GJ;
    Clin Infect Dis; 2013 Aug; 57 Suppl 2():S129-37. PubMed ID: 23884061
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What is killing people with hepatitis C virus infection?
    Grebely J; Dore GJ
    Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can hepatitis C be eradicated in the United States?
    Edlin BR; Winkelstein ER
    Antiviral Res; 2014 Oct; 110():79-93. PubMed ID: 25110202
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program.
    Butner JL; Gupta N; Fabian C; Henry S; Shi JM; Tetrault JM
    J Subst Abuse Treat; 2017 Apr; 75():49-53. PubMed ID: 28237054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.
    Vespasiani-Gentilucci U; Galati G; Gallo P; De Vincentis A; Riva E; Picardi A
    World J Gastroenterol; 2015 Jun; 21(24):7412-26. PubMed ID: 26139987
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reviewing harm reduction for people who inject drugs in Asia: the necessity for growth.
    Stone KA
    Harm Reduct J; 2015 Oct; 12():32. PubMed ID: 26472335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C eradication: A long way to go.
    Waheed Y
    World J Gastroenterol; 2015 Nov; 21(43):12510-2. PubMed ID: 26604658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Potential Reach of Opioid Substitution Settings to Deliver HCV Care to People Who Inject Drugs in Australia.
    Butler K; Day C; Dietze P; Bruno R; Alati R; Burns L
    J Subst Abuse Treat; 2015 Nov; 58():90-4. PubMed ID: 26117080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
    Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
    Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Barriers and facilitators to engaging in hepatitis C management and DAA therapy among general practitioners and drug and alcohol specialists-The practitioner experience.
    Marshall AD; Grebely J; Dore GJ; Treloar C
    Drug Alcohol Depend; 2020 Jan; 206():107705. PubMed ID: 31718924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C, a global issue: access to care and new therapeutic and preventive approaches in resource-constrained areas.
    Lemoine M; Thursz M
    Semin Liver Dis; 2014 Feb; 34(1):89-97. PubMed ID: 24782262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium.
    Matheï C; Bourgeois S; Blach S; Brixko C; Mulkay JP; Razavi H; Robaeys G
    Acta Gastroenterol Belg; 2016; 79(2):227-32. PubMed ID: 27382943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C.
    Spearman CW; Dusheiko GM; Hellard M; Sonderup M
    Lancet; 2019 Oct; 394(10207):1451-1466. PubMed ID: 31631857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial.
    Wade AJ; Doyle JS; Gane E; Stedman C; Draper B; Iser D; Roberts SK; Kemp W; Petrie D; Scott N; Higgs P; Agius PA; Roney J; Stothers L; Thompson AJ; Hellard ME
    Trials; 2018 Jul; 19(1):383. PubMed ID: 30012192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatitis C virus core antigen: A simplified treatment monitoring tool, including for post-treatment relapse.
    Lamoury FMJ; Soker A; Martinez D; Hajarizadeh B; Cunningham EB; Cunningham P; Bruggmann P; Foster GR; Dalgard O; Backmund M; Conway B; Robaeys G; Swan T; Cloherty G; Marks P; Grebely J; Dore GJ; Applegate TL
    J Clin Virol; 2017 Jul; 92():32-38. PubMed ID: 28521211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis C: Part II. Prevention counseling and medical evaluation.
    Moyer LA; Mast EE; Alter MJ
    Am Fam Physician; 1999 Jan; 59(2):349-54, 357. PubMed ID: 9930128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.